The Tissue Engineering Market will grow at highest pace owing to rising Geriatric population
![]() |
Tissue Engineering Market |
Tissue
engineering involves the use of a combination of cells, engineering and
materials methods, and suitable biochemical and physicochemical factors to
establish, regenerate, or replace tissues. It aims to regenerate living tissues
for reconstructing damaged organs or to accelerate tissue repair. Tissue
engineering products help restore or establish normal function in tissues and
organs are used in various applications such as orthopedics, musculoskeletal
and spine, nerve and tissue repair and regeneration. The growing prevalence of
lifestyle diseases, chronic diseases, and life-threatening disorders has
increased the demand for tissue substitutes. With increased life expectancy,
the aging population continues to rise rapidly which is increasing the demand
for tissue substitutes across the globe.
The Global
Tissue Engineering Market Share is estimated to be valued at US$
12,176.84 Bn in 2024 and is expected to exhibit a CAGR of 7.9% over the
forecast period 2024 to 2030.
Key Takeaways
Key players operating in the Tissue engineering market are MAXAM, AEL Mining
Services Ltd., EXSA SA, Enaex, Austin International, Orica Limited, Keltec
Energies, Economic Explosives, IBP Co., Noble Explochem, Accurate Energetic
Systems, LLC., and Detotec North America Inc. The rising prevalence of chronic
diseases and increasing geriatric population are fueling the demand for tissue
engineering products across the globe. The chronic diseases segment accounted
for the largest revenue share in the global tissue engineering market in 2021.
With increasing R&D investment and technological advancements, new tissues
can be formed by combining natural or synthetic materials with living cells or
molecules. These advancements help in developing functional substitute tissues
for diseased or injured tissues.
The growing prevalence of chronic diseases and genetic disorders is driving the
growth of the global tissue engineering market. As per the WHO, chronic
diseases accounted for approximately 60% of all reported deaths in the world in
2018. Moreover, cardiovascular diseases, cancer, respiratory diseases, and
diabetes accounted for around 75% of all reported deaths in 2018. The
increasing cases of chronic diseases have boosted the demand for tissue
substitutes globally.
Technological advancements in the field of regenerative medicine and 3D
bioprinting have expanded tissue engineering applications. Advancements such as
development of bioinks compatible with 3D bioprinting of tissues and organs
have enabled scientists to 3D print tissues and organs. Moreover, advances in
material science, stem cell biology, and biomolecular engineering have enabled
fabrication of scaffolds mimicking native tissues.
Market trends
The market is witnessing increased commercialization of tissue-engineered
products. For instance, in November 2022, Anthropic received approval from the
FDA for its tissue-engineered product EpiPen for emergency use in treating
severe allergic reactions. Also, major players are focusing on development of
new 3D bioprinted tissue-engineered products to cater to the unmet needs.
Investments in regenerative medicine and stem cell research have increased
globally which is accelerating research on tissue-engineered products. For
instance, in 2022, Japan's National Research and Development Agency invested $3
billion over the next decade to support regenerative medicine research.
Market Opportunities
Increased healthcare expenditure and availability of funding for R&D in
regenerative medicines in emerging economies present lucrative growth
opportunities.
The growing focus on development of organoids and organs-on-chips using tissue
engineering approach provides opportunities for innovation and new product
development. Development of viable tissue-engineered organs will address the
issue of organ shortage for transplantation.
Impact of COVID-19 on Tissue Engineering Market Growth
The COVID-19 pandemic has adversely impacted the global tissue engineering
market growth. During the pandemic, non-emergency surgeries were postponed to
avoid unnecessary health risks and focus medical resources on COVID-19
patients. This led to a decline in demand for tissue engineered products used
in reconstructive surgeries. Moreover, international trade barriers and
lockdowns disrupted supply chains, affecting the availability of key materials
used in tissue engineering. However, researchers redirected efforts towards
developing tissue engineered therapies for critical COVID-19 complications like
lung injury and acute respiratory distress syndrome. Going forward, as the
pandemic situation eases, postponed elective surgeries are likely to resume,
driving the tissue engineering market's recovery. Industry players will need to
focus on ensuring supply chain resilience, leveraging digital technologies, and
collaborating with research institutes to develop novel
antiviral/immunomodulatory tissue therapies.
North America leads globally in terms of tissue engineering market value owing
to advanced healthcare infrastructure, rising prevalence of chronic diseases,
and increasing funding for regenerative medicine research. Several top
universities and companies in countries like the US and Canada are engaged in
developing innovative tissue engineered products. Asia Pacific presents
significant growth opportunities due to growing healthcare expenditure, large
patient pools, and government initiatives supporting medical technology
adoption. China in particular is emerging as a major hub for tissue engineering
research and manufacturing. Future strategies should tap into opportunities in
Asia's fast developing markets to further expand globally.
Geographical Regions with Highest Tissue Engineering Market Concentration
North America accounts for the largest share of the global tissue engineering
market in terms of value. Advanced medical technologies, rising healthcare
spending, increasing incidence of lifestyle diseases and trauma injuries are
major factors driving the North American market. The presence of several top
medical device companies and research institutes engaged in tissue engineering
also contributes to its large market size. Meanwhile, countries in Asia Pacific
such as China, India and Japan are emerging markets experiencing rapid growth
owing to growing medical awareness, healthcare reforms expanding insurance
coverage and government funding to develop indigenous medical technologies.
Europe follows North America in tissue engineering market value due to
universal healthcare and strong focus on regenerative medicine across nations
like Germany, UK and France.
For more details on the report, Read- https://www.trendingwebwire.com/tissue-engineering-market-growth-demand-and-overview/
Comments
Post a Comment